2015 Q4 Form 10-Q Financial Statement

#000092471915000027 Filed on November 12, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q3
Revenue $7.700M $10.40M $5.975M
YoY Change 73.81% 74.11% -13.48%
Cost Of Revenue $5.910M $7.280M $4.455M
YoY Change 39.39% 63.43% -13.39%
Gross Profit $1.790M $3.123M $1.520M
YoY Change 842.11% 105.4% -13.76%
Gross Profit Margin 23.25% 30.02% 25.45%
Selling, General & Admin $1.530M $1.366M $1.311M
YoY Change 25.41% 4.22% 6.57%
% of Gross Profit 85.47% 43.75% 86.23%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $170.0K $170.0K $160.0K
YoY Change 0.0% 6.25% 6.67%
% of Gross Profit 9.5% 5.44% 10.52%
Operating Expenses $1.480M $1.366M $1.311M
YoY Change 35.78% 4.22% 6.57%
Operating Profit $310.0K $1.770M $216.8K
YoY Change -134.44% 716.34% -55.3%
Interest Expense -$10.00K $26.60K $28.99K
YoY Change -83.33% -8.24% -26.9%
% of Operating Profit -3.23% 1.5% 13.37%
Other Income/Expense, Net -$7.541K -$29.28K
YoY Change -74.25%
Pretax Income $300.0K $1.762M $187.5K
YoY Change -130.0% 839.81% -58.05%
Income Tax $130.0K $610.0K $75.00K
% Of Pretax Income 43.33% 34.62% 40.0%
Net Earnings $170.0K $1.152M $112.5K
YoY Change -127.42% 924.14% -58.63%
Net Earnings / Revenue 2.21% 11.07% 1.88%
Basic Earnings Per Share $0.24 $0.02
Diluted Earnings Per Share $32.63K $0.23 $0.02
COMMON SHARES
Basic Shares Outstanding 4.853M shares 4.894M shares 4.882M shares
Diluted Shares Outstanding 4.946M shares 4.925M shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.780M $2.020M $5.240M
YoY Change -39.43% -61.45% 68.49%
Cash & Equivalents $3.523M $991.1K $4.237M
Short-Term Investments $1.040M $1.030M $1.000M
Other Short-Term Assets $860.0K $860.0K $830.0K
YoY Change 50.88% 3.61% 13.7%
Inventory $2.490M $2.170M $1.680M
Prepaid Expenses
Receivables $6.795M $10.26M $4.846M
Other Receivables $390.0K $70.00K $130.0K
Total Short-Term Assets $13.51M $15.47M $12.96M
YoY Change 13.17% 19.34% -3.03%
LONG-TERM ASSETS
Property, Plant & Equipment $5.074M $4.465M $4.244M
YoY Change 23.55% 5.2% 3.03%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $268.7K $269.3K $271.1K
YoY Change 5.22% -0.66% -11.66%
Total Long-Term Assets $5.343M $4.734M $4.515M
YoY Change 22.48% 4.85% 2.01%
TOTAL ASSETS
Total Short-Term Assets $13.51M $15.47M $12.96M
Total Long-Term Assets $5.343M $4.734M $4.515M
Total Assets $18.85M $20.20M $17.48M
YoY Change 15.66% 15.6% -1.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.744M $2.812M $1.441M
YoY Change 51.32% 95.11% 42.28%
Accrued Expenses $974.8K $1.159M $1.278M
YoY Change 80.67% -9.34% 15.26%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $440.0K $370.0K $370.0K
YoY Change 22.22% 0.0% 12.12%
Total Short-Term Liabilities $4.528M $6.204M $3.390M
YoY Change 54.5% 83.01% -1.97%
LONG-TERM LIABILITIES
Long-Term Debt $2.080M $2.050M $2.320M
YoY Change -6.73% -11.64% -7.2%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $2.080M $2.050M $2.320M
YoY Change -6.73% -11.64% -7.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.528M $6.204M $3.390M
Total Long-Term Liabilities $2.080M $2.050M $2.320M
Total Liabilities $7.460M $8.851M $6.211M
YoY Change 28.08% 42.51% -5.67%
SHAREHOLDERS EQUITY
Retained Earnings $6.342M $6.363M $6.285M
YoY Change 15.48% 1.24% -0.06%
Common Stock $49.20K $48.94K $48.82K
YoY Change 0.78% 0.25% 0.73%
Preferred Stock
YoY Change
Treasury Stock (at cost) $102.3K $102.3K $102.3K
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares 40.92K shares 40.92K shares 40.92K shares
Shareholders Equity $11.39M $11.35M $11.27M
YoY Change
Total Liabilities & Shareholders Equity $18.85M $20.20M $17.48M
YoY Change 15.66% 15.6% -1.77%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income $170.0K $1.152M $112.5K
YoY Change -127.42% 924.14% -58.63%
Depreciation, Depletion And Amortization $170.0K $170.0K $160.0K
YoY Change 0.0% 6.25% 6.67%
Cash From Operating Activities $1.580M -$600.0K $1.670M
YoY Change -626.67% -135.93% 595.83%
INVESTING ACTIVITIES
Capital Expenditures -$780.0K -$350.0K -$180.0K
YoY Change 1014.29% 94.44% -40.0%
Acquisitions
YoY Change
Other Investing Activities -$10.00K $0.00 -$10.00K
YoY Change -50.0% -100.0% -101.01%
Cash From Investing Activities -$780.0K -$360.0K -$180.0K
YoY Change 680.0% 100.0% -126.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -50.00K 0.000 -100.0K
YoY Change -80.77% -100.0% 400.0%
NET CHANGE
Cash From Operating Activities 1.580M -600.0K 1.670M
Cash From Investing Activities -780.0K -360.0K -180.0K
Cash From Financing Activities -50.00K 0.000 -100.0K
Net Change In Cash 750.0K -960.0K 1.390M
YoY Change -213.64% -169.06% 54.44%
FREE CASH FLOW
Cash From Operating Activities $1.580M -$600.0K $1.670M
Capital Expenditures -$780.0K -$350.0K -$180.0K
Free Cash Flow $2.360M -$250.0K $1.850M
YoY Change -1126.09% -113.51% 242.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000924719
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4852628 shares
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
SMITH MIDLAND CORP
CY2014Q4 smid Accrued Compensation Current
AccruedCompensationCurrent
442651 USD
CY2015Q3 smid Accrued Compensation Current
AccruedCompensationCurrent
698109 USD
CY2014Q3 smid Products Sales And Leasing
ProductsSalesAndLeasing
4558745 USD
smid Products Sales And Leasing
ProductsSalesAndLeasing
13295450 USD
CY2015Q3 smid Products Sales And Leasing
ProductsSalesAndLeasing
8753987 USD
smid Products Sales And Leasing
ProductsSalesAndLeasing
17623720 USD
smid Revenue Recognition Licensing Contract Term
RevenueRecognitionLicensingContractTerm
P5Y
CY2014Q3 smid Shipping And Installation Revenue
ShippingAndInstallationRevenue
1072529 USD
smid Shipping And Installation Revenue
ShippingAndInstallationRevenue
3580769 USD
CY2015Q3 smid Shipping And Installation Revenue
ShippingAndInstallationRevenue
1223599 USD
smid Shipping And Installation Revenue
ShippingAndInstallationRevenue
2636746 USD
CY2014Q4 smid Trade Unbilled
TradeUnbilled
240635 USD
CY2015Q3 smid Trade Unbilled
TradeUnbilled
101618 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1152506 USD
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2811671 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4092924 USD
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10258618 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
539549 USD
CY2015Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1158949 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6629 USD
CY2015Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-20771 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5041438 USD
CY2015Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5062418 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
356253 USD
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
296276 USD
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
254166 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
254166 shares
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2014Q4 us-gaap Assets
Assets
16297916 USD
CY2015Q3 us-gaap Assets
Assets
20202816 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
11935920 USD
CY2015Q3 us-gaap Assets Current
AssetsCurrent
15468849 USD
CY2014Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
1013417 USD
CY2015Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
1026793 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3136063 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4237434 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3572405 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
991143 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1101371 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2581262 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
8000000 shares
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
8000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4881548 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4893548 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4881548 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4893548 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
48815 USD
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
48935 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
117764 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-157552 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1155424 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
859773 USD
CY2014Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4454689 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14385001 USD
CY2015Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7280467 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
16180592 USD
CY2014Q4 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
432274 USD
CY2015Q3 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
1168402 USD
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
441000 USD
CY2015Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
619000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
663000 USD
CY2015Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
598000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
474744 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
499554 USD
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
38431 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
15693 USD
CY2014Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
4352 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
38431 USD
CY2015Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
4066 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
15693 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
761907 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2337909 USD
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
808216 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2429280 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
1520406 USD
us-gaap Gross Profit
GrossProfit
3655818 USD
CY2015Q3 us-gaap Gross Profit
GrossProfit
3122950 USD
us-gaap Gross Profit
GrossProfit
5320515 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
187490 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-304065 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1762056 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1296544 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
75000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-118000 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
610000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
424000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-76586 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1656645 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2450365 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6165694 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-302263 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-53377 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
619400 USD
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
0 USD
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
255458 USD
us-gaap Increase Decrease In Customer Advances And Deposits
IncreaseDecreaseInCustomerAdvancesAndDeposits
-246259 USD
us-gaap Increase Decrease In Customer Advances And Deposits
IncreaseDecreaseInCustomerAdvancesAndDeposits
736128 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
155000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
243000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-261984 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
441789 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
66895 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
123949 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
126100 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-655727 USD
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
204854 USD
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-139017 USD
CY2014Q3 us-gaap Interest Expense
InterestExpense
28993 USD
us-gaap Interest Expense
InterestExpense
87597 USD
CY2015Q3 us-gaap Interest Expense
InterestExpense
26603 USD
us-gaap Interest Expense
InterestExpense
77333 USD
CY2014Q3 us-gaap Interest Income Domestic Deposits
InterestIncomeDomesticDeposits
-289 USD
us-gaap Interest Income Domestic Deposits
InterestIncomeDomesticDeposits
6967 USD
CY2015Q3 us-gaap Interest Income Domestic Deposits
InterestIncomeDomesticDeposits
19062 USD
us-gaap Interest Income Domestic Deposits
InterestIncomeDomesticDeposits
20370 USD
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1373455 USD
CY2015Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1420243 USD
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
353089 USD
CY2015Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
748090 USD
CY2014Q4 us-gaap Liabilities
Liabilities
5824165 USD
CY2015Q3 us-gaap Liabilities
Liabilities
8851207 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16297916 USD
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20202816 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2930801 USD
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6204025 USD
CY2014Q3 us-gaap Licenses Revenue
LicensesRevenue
343821 USD
us-gaap Licenses Revenue
LicensesRevenue
1164600 USD
CY2015Q3 us-gaap Licenses Revenue
LicensesRevenue
425831 USD
us-gaap Licenses Revenue
LicensesRevenue
1240641 USD
CY2014Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
2230364 USD
CY2015Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
2049182 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-225821 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-157008 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-404071 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-868602 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1731263 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1555652 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
112490 USD
us-gaap Net Income Loss
NetIncomeLoss
-186065 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
1152056 USD
us-gaap Net Income Loss
NetIncomeLoss
872544 USD
CY2014Q4 us-gaap Notes Payable Current
NotesPayableCurrent
363821 USD
CY2015Q3 us-gaap Notes Payable Current
NotesPayableCurrent
366894 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
1311041 USD
us-gaap Operating Expenses
OperatingExpenses
3973412 USD
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
1366428 USD
us-gaap Operating Expenses
OperatingExpenses
4006266 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
216772 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-223435 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1769597 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1353507 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
255385 USD
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
269260 USD
us-gaap Sales Revenue Net
SalesRevenueNet
21501107 USD
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
549134 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1635503 USD
CY2014Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5274 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
28513 USD
CY2015Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3368 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-12771 USD
CY2014Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
3000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
19000 USD
CY2015Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
2000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
8000 USD
CY2014Q3 us-gaap Other Income
OtherIncome
3055 USD
us-gaap Other Income
OtherIncome
55728 USD
CY2015Q3 us-gaap Other Income
OtherIncome
9009 USD
us-gaap Other Income
OtherIncome
23565 USD
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-29282 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-80630 USD
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7541 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-56963 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
45503 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
27519 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
398684 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
864814 USD
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
126047 USD
CY2015Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
236123 USD
CY2014Q4 us-gaap Prepaid Taxes
PrepaidTaxes
722948 USD
CY2015Q3 us-gaap Prepaid Taxes
PrepaidTaxes
67221 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
55159 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
97005 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
40116 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
23731 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
21101 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4106611 USD
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4464707 USD
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
280980 USD
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
275114 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5492427 USD
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
6363327 USD
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
5975095 USD
us-gaap Sales Revenue Net
SalesRevenueNet
18040819 USD
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
10403417 USD
CY2015Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
558212 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1576986 USD
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
211933 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
81166 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.52
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.00
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
164000 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
305099 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
211933 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.97
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.78
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.78
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.76
CY2015Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
100000 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
12000 shares
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
10473751 USD
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
11351609 USD
CY2014Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
10576051 USD
CY2015Q3 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
11453909 USD
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
40920 shares
CY2015Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
40920 shares
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
102300 USD
CY2015Q3 us-gaap Treasury Stock Value
TreasuryStockValue
102300 USD
CY2014Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
43516 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2015Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
52197 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
51008 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4925064 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4881548 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4945745 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4943985 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4881548 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4881548 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4893548 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4892977 shares
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjusting Entry</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the third quarter of 2015, the Company made an adjusting journal entry to record </font><font style="font-family:inherit;font-size:10pt;">$240,000</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable and revenue which related to the prior year.&#160; The entry was recorded in the current period since the effects of the adjusting journal entry was immaterial to both the prior and current periods.&#160;</font></div></div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain minor reclassifications have been made in prior year amounts to conform to the current year presentation.</font></div></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name View Source Status
0000924719-15-000027-index-headers.html Edgar Link pending
0000924719-15-000027-index.html Edgar Link pending
0000924719-15-000027.txt Edgar Link pending
0000924719-15-000027-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
smid-20150930.xml Edgar Link completed
smid-20150930.xsd Edgar Link pending
smid-20150930x10xq.htm Edgar Link pending
smid-20150930xex311.htm Edgar Link pending
smid-20150930xex312.htm Edgar Link pending
smid-20150930xex321.htm Edgar Link pending
smid-20150930_cal.xml Edgar Link unprocessable
smid-20150930_def.xml Edgar Link unprocessable
smid-20150930_lab.xml Edgar Link unprocessable
smid-20150930_pre.xml Edgar Link unprocessable